SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-049972
Filing Date
2018-09-06
Accepted
2018-09-06 20:20:27
Documents
1
Period of Report
2018-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4134
  Complete submission text file 0001209191-18-049972.txt   5599
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10445 PACIFIC CENTER CT SAN DIEGO CA 92121
Business Address
GOLD DANIEL P PHD (Reporting) CIK: 0001288233 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50484 | Film No.: 181058747